Литература
51. Wang L., Hao J., Zhang Y., Yang Z., Cao Y., Lu W., Shu Y., Jiang L., Hu Y., Lv W., Liu Y., Dong P. Orai1 mediates tumor-promoting store-operated Ca2+ entry in human gastrointestinal stromal tumors via c-KIT and the extracellular signal-regulated kinase pathway // Tumour Biol. – 2017. – V. 39, No 2. – Art. 1010428317691426, P. 1–11. – doi: 10.1177/1010428317691426.
52. Hasna J., Hague F., Rodat-Despoix L., Geerts D., Leroy C., Tulasne D., Ouadid-Ahidouch H., Kischel P. Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: The p53 connection // Cell Death Differ. – 2018. – V. 25, No 4. – P. 693–707. doi: 10.1038/s41418-017-0007-1.
53. Nabissi M., Morelli M.B., Santoni M., Santoni G. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents // Carcinogenesis. – 2013. – V. 34, No 1. – P. 48–57. – doi: 10.1093/carcin/bgs328.
54. Deveci H.A., Naziroglu M., Nur G. 5-Fluorouracil-induced mitochondrial oxidative cytotoxicity and apoptosis are increased in MCF-7 human breast cancer cells by TRPV1 channel activation but not Hypericum perforatum treatment // Mol. Cell. Biochem. – 2018. – V. 439, No 1–2. – P. 189–198. – doi: 10.1007/s11010-017-3147-1.
55. Almasi S., Kennedy B.E., El-Aghil M., Sterea A.M., Gujar S., Partida-Sanchez S., El Hiani Y. TRPM2 channel-mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK-signaling pathway // J. Biol. Chem. – 2018. – V. 293, No 10. – P. 3637–3650. – doi: 10.1074/jbc.M117.817635.
56. Koh D.W., Powell D.P., Blake S.D., Hoffman J.L., Hopkins M.M., Feng X. Enhanced cytotoxicity in triple-negative and estrogen receptorpositive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channel // Oncol. Rep. – 2015. – V. 34, No 3. – P. 1589–1598. – doi: 10.3892/or.2015.4131.
57. Liu X., Zou J., Su J., Lu Y., Zhang J., Li L., Yin F. Downregulation of transient receptor potential cation channel, subfamily C, member 1 contributes to drug resistance and high histological grade in ovarian cancer // Int. J. Oncol. – 2016. – V. 48, No 1. – P. 243–252. – doi: 10.3892/ijo.2015.3254.
58. Zhang P., Liu X., Li H., Chen Z., Yao X., Jin J., Ma X. TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway // Sci. Rep. – 2017. – V. 7, No 1. – Art. 3158, P. 1–13. – doi: 10.1038/s41598-017-03230-w.
59. Wen L., Liang C., Chen E., Chen W., Liang F., Zhi X., Wei T., Xue F., Li G., Yang Q., Gong W., Feng X., Bai X., Liang T. Regulation of multi-drug resistance in hepatocellular carcinoma cells is TRPC6/calcium dependent // Sci. Rep. – 2016. – V. 6. – Art. 23269, P. 1–14. – doi: 10.1038/srep23269.
60. Tsunoda T., Koga H., Yokomizo A., Tatsugami K., Eto M., Inokuchi J., Hirata A., Masuda K., Okumura K., Naito S. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines // Oncogene. – 2005. – V. 24, No 8. – P. 1396–1402. – doi: 10.1038/sj.onc.1208313.
61. Schrödl K., Oelmez H., Edelmann M., Huber R.M., Bergner A. Altered Ca2+-homeostasis of cisplatin-treated and low level resistant non-small-cell and small-cell lung cancer cells // Cell. Oncol. – 2009. – V. 31, No 4. – P. 301–315. – doi: 10.3233/CLO-2009-0472.
62. Pillozzi S., D’Amico M., Bartoli G., Gasparoli L., Petroni G., Crociani O., Marzo T., Guerriero A., Messori L., Severi M., Udisti R., Wulff H., Chandy K.G., Becchetti A., Arcangeli A. The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome cisplatin resistance in colorectal cancer cells // Br. J. Cancer. – 2018. – V. 118, No 2. – P. 200–212. – doi: 10.1038/bjc.2017.392.
63. Agarwal J.R., Griesinger F., Stuhmer W., Pardo L.A. The potassium channel ether a go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia // Mol. Cancer. – 2010. – V. 9. – Art. 18, P. 1–16. – doi: 10.1186/1476-4598-9-18.
64. Chen Q., Liu X., Luo Z., Wang S., Lin J., Xie Z., Li M., Li C., Cao H., Huang Q., Mao J., Xu B. Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression // J. Cell. Physiol. – 2019. – V. 234, No 5. – P. 6611–6623. – doi: 10.1002/jcp.27402.
65. Marin M., Poret A., Maillet G., Leboulenger F., Le Foll F. Regulation of volume-sensitive Cl-channels in multi-drug resistant MCF7 cells // Biochem. Biophys. Res. Commun. – 2005. – V. 334, No 4. – P. 1266–1278. – doi: 10.1016/j.bbrc.2005.07.010.
66. Chen Y., Wei X., Yan P., Han Y., Sun S., Wu K., Fan D. Human mitochondrial Mrs2 protein promotes multidrug resistance in gastric cancer cells by regulating p27, cyclin D1 expression and cytochrome C release // Cancer Biol. Ther. – 2009. – V. 8, No 7. – P. 607–614. – doi: 10.4161/cbt.8.7.7920.
67. Kischel P., Girault A., Rodat-Despoix L., Chamlali M., Radoslavova S., Abou Daya H., Lefebvre T., Foulon A., Rybarczyk P., Hague F., Dhennin-Duthille I., Gautier M., Ouadid-Ahidouch H. Ion channels: New actors playing in chemotherapeutic resistance // Cancers (Basel). – 2019. – V. 11, No 3. – Art. 376, P. 1–28. – doi: 10.3390/cancers11030376.
68. Hilgarth M. Aspects in quality assurance in gynecological cytology // Der Gynäkologe. – 1990. – V. 23, No 6. – P. 312–318.
69. Balaji S.A., Udupa N., Chamallamudi M.R., Gupta V., Rangarajan A. Role of the drug transporter ABCC3 in breast cancer chemoresistance // PLoS ONE. – 2016. – V. 11, No 5. – Art. e0155013, P. 1–22. – doi: 10.1371/journal.pone.0155013.
70. Abbasifarid E., Sajjadi-Jazi S.M., Beheshtian M., Samimi H., Larijani B., Haghpanah V. The role of ATP-binding cassette transporters in the chemoresistance of anaplastic thyroid cancer: A systematic review // Endocrinology. – 2019. – V. 160, No 8. – P. 2015–2023. – doi: 10.1210/en.2019-00241.
71. Bindea G., Mlecnik B., Fridman W.H., Pages F., Galon J. Natural immunity to cancer in humans // Curr. Opin. Immunol. – 2010. – V. 22, No 2. – P. 215–222. – doi: 10.1016/j.coi.2010.02.006.
72. Colden-Stanfield M. Adhesion-dependent modulation of macrophage K+ channels // Adv. Exp. Med. Biol. – 2010. – V. 674. – P. 81–94. – doi: 10.1007/978-1-4419-6066-5_8.
73. Lopez-Castejon G., Theaker J., Pelegrin P., Clifton A.D., Braddock M., Surprenant A. P2x7 receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases // J. Immunol. – 2010. – V. 185, No 4. – P. 2611–2619. – doi: 10.4049/jimmunol.1000436.
74. Bukowski K., Kciuk M., Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy // Int. J. Mol. Sci. – 2020. – V. 21, No 9. – Art. 3233, P. 1–24. – doi: 10.3390/ijms21093233.
75. Ham I.H., Oh H.J., Jin H., Bae C.A., Jeon S.M., Choi K.S., Son S.Y., Han S.U., Brekken R.A., Lee D., Hur H. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer // Mol. Cancer. – 2019. – V. 18, No 1. – Art. 68, P. 1–14. – doi: 10.1186/s12943-019-0972-8.
76. Wang Y., Qu Y., Niu X.L., Sun W.J., Zhang X.L., Li L.Z. Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells // Cytokine. – 2011. – V. 56, No 2. – P. 365–375. – doi: 10.1016/j.cyto.2011.06.005.
77. Song S., Wientjes M.G., Gan Y., Au J.L. Fibroblast growth factors: An epigenetic mechanism of broad spectrum resistance to anticancer drugs // Proc. Natl. Acad. Sci. U. S. A. – 2000. – V. 97, No 15. – P. 8658–8663. – doi: 10.1073/pnas.140210697.
78. Shain K.H., Dalton W.S. Cell adhesion is a key determinant in de novo multidrug resistance (MDR): New targets for the prevention of acquired MDR // Mol. Cancer Ther. – 2001. – V. 1, No 1. – P. 69–78.
79. Shain K.H., Dalton W.S. Environmental-mediated drug resistance: A target for multiple myeloma therapy // Expert Rev. Hematol. – 2009. – V. 2, No 6. – P. 649–662. – doi: 10.1586/ehm.09.55.
80. Castells M., Thibault B., Delord J.P., Couderc B. Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death // Int. J. Mol. Sci. – 2012. – V. 13, No 8. – P. 9545–9571. – doi: 10.3390/ijms13089545.
